No matter what happens to the industry, though, there are plenty of excellent healthcare stocks that look attractive heading ...

Portfolio manager highlights AbbVie, Pfizer and Medtronic as compelling large-cap health care dividend plays with growth and ...

Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx liquid embolic system demonstrates.

The medtech job market faces major shifts in 2026 due to federal layoffs, AI adoption, and M&A activity. Versatile skills ...

Salmon retired from Medtronic in September after a more than 20-year tenure at the medtech giant. Most recently, Salmon ...

Point-of-care infectious disease diagnostics valued at $53 billion in 2024 are projected to nearly double by 2033, driven by ...

The Shelford Group has today launched the Shelford Surgical Training in Advanced Robotic Technology (START) program, which ...

Medtronic (MDT) has quietly outperformed the broader healthcare space over the past year, and that steady climb is getting investors to revisit whether this long standing medical device leader still ...

Citi analyst Joanne Wuensch maintained a Buy rating on Medtronic today and set a price target of $117.00. According to TipRanks, Wuensch is a 4-star analyst with an average return of 5.2% and a 58.59% ...

Piper Sandler analyst Matthew O’Brien maintained a Hold rating on Medtronic today and set a price target of $105.00. O’Brien covers the Healthcare sector, focusing on stocks such as Medtronic, Dexcom, ...

Intuitive's da Vinci SP system secures FDA clearance for hernia, gallbladder, appendix surgeries amid growing competition.

Intuitive Surgical (ISRG) stock and Haemonetics (HAE) stock slip as Citi downgrades the firms as part of its 2026 outlook on the MedTech sector. Read more here.